| Treatment(1) | P < (2) | |||||||
Fatty acid (g/100g) | Pre-trial(3) | SS | SO | SS-FO | SO-FO | SEM | A | B | A × B |
C6:0 | 1.11 | 0.30 | 0.38 | 0.21 | 0.35 | 0.04 | 0.06 | 0.30 | 0.52 |
C8:0 | 0.91 | 0.28 | 0.26 | 0.13 | 0.21 | 0.03 | 0.03 | 0.37 | 0.15 |
C10:0 | 2.03 | 0.70 | 0.68 | 0.31 | 0.54 | 0.08 | 0.21 | 0.01 | 0.18 |
C10:1 | 0.28 | 0.63 | 0.07 | 0.03 | 0.04 | 0.01 | 0.33 | 0.05 | 0.80 |
C12:0 | 2.49 | 1.03 | 1.10 | 0.56 | 0.90 | 0.12 | 0.13 | 0.03 | 0.31 |
C12:1 | 0.16 | 0.06 | 0.06 | 0.03 | 0.04 | 0.00 | 0.13 | 0.00 | 0.14 |
C14:0 | 9.13 | 4.66 | 5.20 | 2.71 | 4.80 | 0.42 | 0.02 | 0.03 | 0.11 |
C14:1 + isoC15 | 1.10 | 0.71 | 0.73 | 0.55 | 0.62 | 0.02 | 0.10 | 0.00 | 0.34 |
C15:0 | 2.01 | 1.20 | 1.57 | 0.90 | 1.39 | 0.10 | 0.01 | 0.06 | 0.58 |
C15:1 | 0.42 | 0.24 | 0.21 | 0.23 | 0.26 | 0.01 | 0.74 | 0.26 | 0.10 |
C16:0 | 27.14 | 18.7a | 18.09a | 17.41ª | 21.20b | 0.47 | 0.01 | 0.10 | 0.00 |
C16:1 | 3.10 | 1.98 | 2.36 | 2.22 | 2.76 | 0.17 | 0.03 | 0.10 | 0.63 |
C17:0 | 0.78 | 0.57 | 0.55 | 0.58 | 0.57 | 0.01 | 0.50 | 0.61 | 0.86 |
C17:1 | 0.52 | 0.27b | 0.35a | 0.39ª | 0.37ª | 0.01 | 0.14 | 0.00 | 0.02 |
C18:0 | 9.53 | 15.6 | 12.53 | 7.12 | 5.73 | 0.97 | 0.05 | 0.00 | 0.37 |
trans-C18:1(4) | 2.79 | 13.47b | 14.31b | 33.54ª | 27.78c | 1.24 | 0.09 | 0.00 | 0.00 |
cis-C18:1 | 28.20 | 28.37 | 30.38 | 16.60 | 16.96 | 0.87 | 0.22 | <.00 | 0.38 |
C18:2 | 1.79 | 2.77 | 1.60 | 2.50 | 1.43 | 0.11 | <.00 | 0.11 | 0.63 |
C18:3 | 0.63 | 0.58 | 0.48 | 0.86 | 0.87 | 0.04 | 0.30 | 0.00 | 0.25 |
CLA |
|
|
|
|
|
|
|
|
|
cis-9, trans-11 | 1.39 | 2.62 | 3.11 | 3.66 | 4.18 | 0.41 | 0.26 | 0.04 | 0.97 |
cis-12, trans-10 | - | 0.09 | 0.10 | 0.08 | 0.08 | 0.02 | 0.85 | 0.63 | 0.89 |
cis-9, cis-11 | 0.06 | 0.05 | 0.06 | 0.09 | 0.08 | 0.00 | 0.62 | 0.04 | 0.25 |
trans-9, trans-11 | 0.07 | 0.10 | 0.12 | 0.12 | 0.18 | 0.01 | 0.04 | 0.05 | 0.32 |
Total CLA | 1.52 | 2.82 | 3.38 | 3.96 | 4.51 | 0.42 | 0.23 | 0.03 | 0.99 |
C16:0 + C16:1 | 30.24 | 20.6a | 20.45ª | 19.63a | 24.00b | 0.62 | 0.01 | 0.09 | 0.01 |
C20:5n−3 (EPA) | 0.02 | 0.03 | 0.023 | 0.06 | 0.05 | 0.00 | 0.23 | 0.01 | 0.45 |
C22:6n−3 (DHA) | - | 0.03 | 0.023 | 0.08 | 0.06 | 0.01 | 0.30 | 0.01 | 0.88 |
De novo FA (C4:0-C15:1) | 19.63 | 9.21 | 10.30 | 5.60 | 9.19 | 0.74 | 0.02 | 0.01 | 0.14 |
Preformed FA (>C17:0) | 45.92 | 64.56a | 63.46ª | 65.60a | 58.36b | 1.30 | 0.01 | 0.17 | 0.05 |
CLA/trans-C18:1 | 0.5 | 0.21 | 0.21 | 0.10 | 0.15 | 0.01 | 0.22 | 0.00 | 0.20 |
AI(5) | 1.88 | 0.80b | 0.80b | 0.50a | 0.80b | 0.05 | 0.02 | 0.02 | 0.03 |